FOXO3 and chronic obstructive pulmonary disease: Specifically, the anti-aging SIRT1, that is reduced in lungs of COPD patients, seems to protect against emphysema through FOXO3 (Forkhead box O3)-mediated reduction of cellular senescence, independently of inflammation [53].